FDA
FDA Approves First Pediatric Myopia-Slowing Eyeglass Lenses in US
100% left coverage4 sources
FDA
Top News
FDA, Abortion
US Health Secretary RFK Jr. launches FDA safety review of abortion pill mifepristone amid political scrutiny
100% left coverage4 sources
FDA, Markets
HeartFlow Cleared by FDA; Cigna Coverage Oct. 1
50% center coverage3 sources
FDA
Catalent Quality Problems Trigger Scholar Rock CRL
50% center coverage3 sources
FDA, Markets
EssilorLuxottica Secures FDA Authorization for Myopia Control Lens Slowing Progression 71%
67% center coverage3 sources
FDA
Novartis Gains FDA Approval for Oral BTK Inhibitor Remibrutinib Treating Chronic Spontaneous Urticaria
67% left coverage3 sources
First 100 Days
See how you scored in predicting Trump's first 100 days
Latest News
FDA
Novartis Gains FDA Approval for Oral BTK Inhibitor Remibrutinib Treating Chronic Spontaneous Urticaria
67% left coverage3 sources
FDA
Novartis Gains FDA Approval for Oral BTK Inhibitor Remibrutinib Treating Chronic Spontaneous Urticaria
67% left coverage3 sources
FDA
OS Therapies Plans Dual UK US OST-HER2 Regulatory Filings 2025
100% left coverage1 source
FDA
OS Therapies Plans Dual UK US OST-HER2 Regulatory Filings 2025
100% left coverage1 source
FDA
FDA Official Criticizes Aurinia’s Lupus Drug Toxicity amid Approval Review
100% left coverage2 sources
FDA
FDA Official Criticizes Aurinia’s Lupus Drug Toxicity amid Approval Review
100% left coverage2 sources
FDA, Markets
Crinetics Pharma Shares Soar 35% After FDA Approves Acromegaly Drug
100% left coverage1 source
FDA, Markets
Crinetics Pharma Shares Soar 35% After FDA Approves Acromegaly Drug
100% left coverage1 source
FDA
FDA Approves J&J TREMFYA for Pediatric Psoriasis Arthritis
100% left coverage1 source
FDA
FDA Approves J&J TREMFYA for Pediatric Psoriasis Arthritis
100% left coverage1 source
FDA, Biotech
IO Biotech Faces FDA Rejection of Cylembio, Plans New Melanoma Study, Cuts Workforce 50%
50% center coverage2 sources
FDA, Biotech
IO Biotech Faces FDA Rejection of Cylembio, Plans New Melanoma Study, Cuts Workforce 50%
50% center coverage2 sources
FDA, Biotech
Federal Judge Allows BioXcel Shareholders Amended Suit Over FDA Trial Compliance
50% center coverage2 sources
FDA, Biotech
Federal Judge Allows BioXcel Shareholders Amended Suit Over FDA Trial Compliance
50% center coverage2 sources
First 100 Days
See how you scored in predicting Trump's first 100 days
Most Reported By
News from FDA
News from FDA